Is Shattuck Labs Inc (STTK) overvalued? · rev $5.7M
Shattuck Labs Inc (STTK) is a biotechnology company listed on US.
This page asks whether Shattuck Labs Inc (STTK) looks expensive on cached numbers — not a short thesis.
Latest reported STTK revenue for 2024-12-31 was $5.7M. Net income was -$75.4M. Revenue was up 245.3% from 2023-12-31 to 2024-12-31. STTK currently screens at market cap $351.2M.
STTK currently screens at market cap $351.2M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next STTK 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the STTK stock page for the full model, not this heading.
Not investment advice.